LAWSUITS FILED AGAINST DOYU, GOSS and LBRT - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / May 7, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

DouYu International Holdings Limited (NASDAQ:DOYU)

CONTACT JAKUBOWITZ ABOUT DOYU:
https://claimyourloss.com/securities/douyu-international-holdings-limited-loss-submission-form/?id=6406&from=1

Class Period : stock in the initial public offering pursuant and/or traceable to the documents used by defendants to conduct the initial public offering.

Lead Plaintiff Deadline : May 26, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: as of the initial public offering: (i) DouYu’s risks related to its top streamers had materialized, including that: (a) a top streamer was actively misrepresenting herself on DouYu’s platform;and (b) costs associated with retaining top streamers was swelling; (ii) DouYu did not ensure that all of its products were fully compliant with current regulatory requirements before those products became available online; and (iii) key interactive features of DouYu’s “lucky draw”were non-compliant with current regulatory requirements.

Gossamer Bio, Inc. (NASDAQ:GOSS)

CONTACT JAKUBOWITZ ABOUT GOSS:
https://claimyourloss.com/securities/gossamer-bio-inc-loss-submission-form/?id=6406&from=1

Class Period : common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.

Lead Plaintiff Deadline : June 2, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer’s GB001 trial failures; (2) the purported clinical validation of Novartis’ oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

Liberty Oilfield Services, Inc. (NYSE:LBRT)

CONTACT JAKUBOWITZ ABOUT LBRT:
https://claimyourloss.com/securities/liberty-oilfield-services-inc-loss-submission-form/?id=6406&from=1

Class Period : securities pursuant and/or traceable to the documents issued in connection with the Company’s January 2018 initial public offering.

Lead Plaintiff Deadline : June 2, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing and its competition was not decreasing; and (4) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/588909/LAWSUITS-FILED-AGAINST-DOYU-GOSS-and-LBRT--Jakubowitz-Law-Pursues-Shareholders-Claims

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.